Neurocrine Biosciences is a California-based biopharmaceutical company that develops therapeutics for the treatment of neurological and neuroendocrine disorders.
Business Model:
Revenue: $1.4B
Employees: 501-1,000
Address: 12780 El Camino Real
City: San Diego
State: CA
Zip: 92130
Country: US
Neurocrine Biosciences is a California-based biopharmaceutical company that develops therapeutics for the treatment of neurological and neuroendocrine disorders.
Contact Phone:
+18586177600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/31/1996
Ticker Symbol:
NBIX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2023 | Voyager Therapeutics | Post-IPO Equity | 39M |
12/2019 | Xenon Pharmaceuticals | Post-IPO Equity | 0 |
12/2019 | Xenon Pharmaceuticals | Post-IPO Equity | 0 |
Announced Date | Name | Price |
---|---|---|
8/2022 | Diurnal Group | |
3/1998 | Northwest Neurologic |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|